Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting

BACKGROUND: In this study, we investigated the risk factors of acquired T790M mutation among patients with lung adenocarcinoma with epidermal growth factor receptor (EGFR) tyrosine mutation who were treated with EGFR‐tyrosine kinase inhibitors (TKIs). The aim was to identify the clinical impact of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Yunha, Kim, Ho Cheol, Kim, Young‐Chul, Jang, Seung Hun, Lee, Kye Young, Lee, Shin Yup, Lee, Sang Hoon, Lee, Sung Yong, Yoon, Seong Hoon, Ryu, Jeong‐Seon, Jang, Tae Won, Chang, Yoon Soo, Kim, Seung Joon, Park, Chan Kwon, Lee, Jeong Eun, Jung, Chi Young, Choi, Chang‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952806/
https://www.ncbi.nlm.nih.gov/pubmed/33529490
http://dx.doi.org/10.1111/1759-7714.13857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952806/
https://www.ncbi.nlm.nih.gov/pubmed/33529490
http://dx.doi.org/10.1111/1759-7714.13857

Ejemplares similares